Skip to main content
Fig. 5 | Molecular Neurodegeneration

Fig. 5

From: Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum

Fig. 5

Correlation between the pTau biomarkers and tau PET (average SUVR of the regions corresponding to Braak stages I-IV) in the TRIAD cohort, for pTau-181 (A), pTau-199 (B), pTau-202 (C), pTau-205 (D), pTau-217 (E), pTau-231 (F) and pTau-396 (G) and tau pathology. Abbreviations: Aβ, amyloid-β; AD, Alzheimer’s disease; CU-, Aβ-negative cognitively unimpaired; CU + , Aβ-positive cognitively unimpaired; frontotemporal dementia; MCI + , Aβ-positive mild cognitive impairment; Non-AD, Aβ-negative “AD” dementia or mild cognitive impairment patients; p, P value of the correlation test; PET, positron emission tomography; R, Spearman rank correlation coefficient; SUVR, standard uptake value ratio

Back to article page